Lannett readying to ship two new generics
Lannett Co. has received Food and Drug Administration approvals for a pair of new generic products.
Supplier News
Mylan releases generic version of Ultram
Mylan N.V. has rolled out tramadol hydrochloride extended-release tablets, a chronic pain medication, in the United States. The drug maker said its product comes in dosages of 100 mg, 200 mg and 300 mg and is a generic version of Ultram ER tablets from Valeant Pharmaceuticals International.
Campbell to phase out BPA from packaging
Campbell Soup Co. plans to complete a transition to cans that do not use bisphenol A (BPA) linings by the middle of 2017.The food company said late Monday that it began using cans with linings made from acrylic or polyester materials earlier this month and will continue to introduce the new linings
Novo Nordisk breaks ground on diabetes medicine facility
Novo Nordisk Inc. has broken ground on a new $1.8 billion diabetes medicine production facility in Clayton, N.C. The 833,000-square-f00t Clayton facility will make active pharmaceutical ingredients (API) for a range of Novo Nordisk’s current and future GLP-1 and insulin medicines.
NFI readies launch of Lidocare Pain Relief Patch
NFI Consumer Products is set to roll out Lidocare Pain Relief Patch, which the company calls the first lidocaine patch available over the counter.
Colgate-Palmolive names senior execs to new roles
Colgate-Palmolive Co. has appointed three of its senior executives to new positions. The consumer products giant said Monday that P.
Revlon tabs Colgate-Palmolive’s Garcia as new CEO
Colgate-Palmolive Co. executive Fabian Garcia is joining Revlon Inc. as president and chief executive officer. Revlon said Monday that Garcia is slated to take the CEO reins on April 15.
Amneal ships generic of Voltaren Gel
Amneal Pharmaceuticals LLC has launched diclofenac sodium topical gel 1%, a pain reliever for osteoarthritis, in the United States.
Pinnacle Foods CEO to become Keurig’s chief exec
Robert Gamgort, chief executive officer of Pinnacle Foods Inc., is leaving the company next month to join Keurig Green Mountain Inc. as CEO. Plans call for Gamgort to take the helm as CEO at Keurig on May 2. He will replace Brian Kelley, who will become vice chairman of the board. Keurig
Perrigo, Allergan release Mucinex store-brand tablets
Perrigo Co. plc and Allergan plc have begun shipping 1,200-mg guaifenesin extended-release tablets, an expectorant, to retail and wholesale customers.
Glenmark cleared to market Evista generic
Glenmark Pharmaceuticals Inc. USA has received final approval from the Food & Drug Administration for raloxifene hydrochloride tablet. Glenmark said Wednesday that its raloxifene product is a generic equivalent of Evista tablets (60 mg) from Eli Lilly and Co.
Innovation collaborates on pharmacy operations paper
The Advanced Systems Division of pharmacy automation provider Innovation partnered with the Binghamton University Watson Institute for Systems Excellence (BU WISE) on a thesis paper published in the journal Expert Systems With Applications (ESWA).
Tec Labs launches Tecnu Bites & Stings textured wipes
Tec Labs has introduced Tecnu Bites & Stings Medicated Itch and Pain Relief Wipes, which feature a new technology for treating insect bites and bee stings. The company said Wednesday that each wipe has one side that is textured and one that is smooth, a feature trademarked as Tecnu Textures.
Camber rolls out Zocor, Valcyte generics
Camber Pharmaceuticals has launched two new generic drug products. The company has released simvastatin tablets, a cholesterol-lowering medication, in strengths of 5 mg, 10 mg, 20 mg, 40 mg and 80 mg.
Creme of Nature enhances Certified Natural Ingredients hair care line
Creme of Nature has introduced its new and improved Certified Natural Ingredients product line of three natural ingredient families.
Twinlab announces CEO succession
Nutritional supplements maker Twinlab Consolidated Holdings Inc. has named Naomi Whittel as president and chief executive officer. Twinlab said Whittel takes the reins from Tom Tolworthy, who is leaving the company to pursue other ventures.